• <table id="gigg0"></table>
  • west china medical publishers
    Author
    • Title
    • Author
    • Keyword
    • Abstract
    Advance search
    Advance search

    Search

    find Author "LI Peng." 2 results
    • TREATMENT OF DISTAL HUMERUS FRACTURE WITH DOUBLE-PLATING FIXATION

      To investigate the method and cl inical effect of double-plating fixation in treatment of distal humerus fractures. Methods From April 2003 to January 2009, 21 patients with distal humerus fracture were treated with l imited contact compression plate and reconstruction plate via posterior elbow incision and approach inside and outside the edge of both sides of the triceps. There were 12 males and 9 females, aged from 20 to 63 years (39 years on average). The causes of injury were fall ing in 13 cases, traffic accident in 6 cases, and fall ing from height in 2 cases. According to the classification of Association for the Study of Internal Fixation (AO/ASIF), 8 cases were classified as type 12-B1, 2 as type 12-B2, 7 as type12-B3, 3 as type 13-A2, and 1 as type 13-A3. The course of disease averaged 4.8 days. Results Secretion was observed at incision in 1 case 2 weeks after operation, and incision healed after dressing change; other incisions healed by first intention. Transient numbness of ring and l ittle fingers occurred in 2 cases 2 days after operation; no iatrogenic nerve paralysis occurred. All patients were followed up 13 to 18 months (15 months on average). The X-ray films showed bone healed 6 months after operation. No postoperative joint adhesion occurred, and the motion of elbow joint ranged from 0° to 135°. According to Morrey evaluation standard, the results were excellent in 17 cases, good in 2 cases, and fair in 2 case; the excellent and good rate was 90.5%. Conclusion Double-plating fixation has the advantages of wide indications, rigid internal fixation, and significant curative effects in treatment of distal humerus fractures.

      Release date:2016-08-31 05:48 Export PDF Favorites Scan
    • Effects of Ecdysterone on the Expression of Tumor Necrosis Factorα and Nuclear Factor κ B in Nonalcoholic Fatty Liver Disease of Rats

      摘要:目的: 研究蛻皮甾酮對非酒精性脂肪性肝病大鼠模型腫瘤壞死因子α(TNFα)與核因子κB(NFκB)表達的影響,并探索其可能的作用機制。 方法 :健康成年SD大鼠36只,隨機分為正常對照組12只與實驗組24只;正常對照組喂以普通基礎飼料,實驗組應用高脂飼料喂養。實驗12周末時將造模成功的實驗組大鼠隨機分為模型組與蛻皮甾酮治療組2個亞組,每組12只;正常對照組喂以普通基礎飼料至16周,模型組繼續應用改良高脂飼料喂養至16周,蛻皮甾酮治療組大鼠在高脂飲食同時加用蛻皮甾酮灌胃。實驗16周末時處死3組所有大鼠;檢測肝臟指數,血清與肝組織生化指標及肝組織病理改變;ELISA法檢測肝臟TNFα水平;免疫組化檢測各組大鼠肝組織中核因子κB蛋白表達情況。 結果 :蛻皮甾酮治療組血清膽固醇(TC)、丙氨酸氨基轉移酶(ALT)和天門冬氨酸氨基轉移酶(AST)明顯低于模型組(212±058比263±024,Plt;005;5336±1848比8460±3627,P<005;14020±3595比24359±3638,P<001);蛻皮甾酮治療組與模型組相比肝組織丙二醛(MDA)水平降低明顯(18454±1645比23928±2376,P<001),超氧化物歧化酶(SOD)活力增加顯著(942±052比518±043,P<001),肝臟指數顯著降低(435±037比504±046,P<001),肝組織脂肪變性程度和炎癥活動度明顯減輕(546±037比630±049,P<001)。蛻皮甾酮治療組與模型組相比TNFα與核因子κB水平明顯減輕(4304±748比6156±727,2465±539比4504±746,P值均<001)。 結論 :蛻皮甾酮具有改善高脂飲食誘發的非酒精性脂肪性肝病大鼠肝臟酶學功能,通過增加肝組織SOD的含量和減少MDA的含量來減輕肝組織氧化應激水平,減輕肝組織TNFα和核因子κB來減輕肝臟炎癥,發揮防治非酒精性脂肪性肝病的作用。Abstract: Objective: To investigate the effect and possible mechanism of ecdysterone on the expression of tumor necrosis factoralpha (TNFα) and nuclear factor κ B (NFκB) in rats with nonalcoholic fatty liver disease of rats. Methods : A total of 36 male Sprague Dawley rats were randomly divided into two groups, who were fed with highfat diet (experimental group, n=24) and normal basic food (normal control, n=12) respectively. At the end of the 12th week, the experimental group was randomly divided into two subgroups: model group and ecdysterone group, each group contained 12 rats. From the 13th week, the rats in the normal control group and model group were lavaged with normal sodium, and the rats in the ecdysterone group were lavaged with ecdysterone at 10 mg·kg-1·d-1. At the end of the 16th week, all rats were weighed, narcotized, sacrificed, and the liver index, biochemical indicators in serum and liver tissues and the hepatic pathological changes were observed. The expression of TNFα was detected by ELISA and the expression of NFκB was measured by immunohistochemical staining. Results : At the end 16th week in ecdysterone group, the serum levels of cholesterol (TC), alanine aminotransferase (ALT) and aspartate aminotransferase (AST) were reduced markedly (212±058 vs 263±024 and 5336±1848 vs 8460±3627, both P<005; 14020±3595 vs 24359±3638, P<001); the tissue content of malondialdehyde (MDA) was decreased evidently (18454±1645 vs 23928±2376, P<001), while the activity of superoxide dismutase (SOD) was enhanced notably (942±052 vs 518±043, P<001); the liver index was decreased significantly in comparison with that inmodel group (435±037 vs 504±046, P<001); the degree of fatty degeneration and inflammation were relieved dramatically (546±037 vs 630±049, P<001). The expression of TNFα and the levels of NFκB were significantly lower (4304±748 vs 6156±727 and 2465±539 vs 4504±746, both P<001) in ecdysterone group compared with model group. Conclusion : The effects of ecdysterone in preventing NAFLD in rats could be related to the increase of SOD content in hepatic tissue and the decrease of MDA content, tumor necrosis factorα and NFκB.

      Release date:2016-09-08 10:12 Export PDF Favorites Scan
    1 pages Previous 1 Next

    Format

    Content

  • <table id="gigg0"></table>
  • 松坂南